IMVT
Immunovant, Inc. · Healthcare
Chief Development Officer Julia G. Butchko sold $33K of Immunovant, Inc.
Sold$32,833
$31.18Price
1,053Shares
What IMVT did after the filing
- The stock from Wed, Apr 10 close, $30.88
- −4.3%
- S&P 500, same days
- +3.1%
Measured over 30 trading days, to the May 22 close.
Traded Tue, Apr 9. Filed Wed, Apr 10, 12:16 PM ET, during the session. Returns use the Apr 10 close and the May 22 close. Not investment advice.